Abstract: An audio communication system is provided for generating an audio output for users in a region, the system comprising a plurality of portable communications devices for use by a respective plurality of users, each communications device comprising a microphone for inputting an audio signal by a user, a loudspeaker for generating an audio output for said user, said loudspeaker being adapted to output said audio output in at least a first frequency band, and a wireless interface for wireless communication to transmit said audio signals from said microphone and receive audio signals derived from an audio source for generating said audio output by said loudspeaker; and at least one low frequency loudspeaker device having an interface for receiving audio signals derived from a microphone of another communications device, and a low frequency loudspeaker adapted to output a low frequency audio output in said region only in a second frequency band lower than said first frequency band.

Abstract: A canopy structure arrangement particularly for conducting repairs on a vehicle has a support frame re-configurable between a collapsed configuration and an expanded configuration; and an expansion support such as a tether to support the frame as it is manually expanded from the collapsed configuration to the expanded configuration. A ground anchor arrangement provides securing of the canopy structure. The arrangement permits ease of erection of the canopy structure.

Abstract: A device for de-energizing an energized branch electrical circuit is described, as well as related processes. The device includes a circuit breaker, which itself includes a breaker switch, an input terminal for receiving current, and an output terminal for directing current out of the breaker. A plug is also incorporated into the device, so that the device can be inserted into an electrical receptacle in the branch electric circuit. One or more power indicators, such as an LED light or voltmeter, are also incorporated into the device. When the device is plugged into a receptacle of the branch circuit, the breaker switch can then be turned on, resulting in a short-circuit, which de-energizes the branch electrical circuit. The device may also include a holder, which is capable of retaining at least one electrical adapter.

Abstract: A device for de-energizing an energized branch electrical circuit is described, as well as related processes. The device includes a circuit breaker, which itself includes a breaker switch, an input terminal for receiving current, and an output terminal for directing current out of the breaker. A plug is also incorporated into the device, so that the device can be inserted into an electrical receptacle in the branch electric circuit. One or more power indicators, such as an LED light or voltmeter, are also incorporated into the device. When the device is plugged into a receptacle of the branch circuit, the breaker switch can then be turned on, resulting in a short-circuit, which de-energizes the branch electrical circuit. The device may also include a holder, which is capable of retaining at least one electrical adapter.

Abstract: Dimeric inhibin concentration can be used in the determination of the risk of a women carrying an unborn child affected by chromosomal abnormalities, e.g. Downs Syndrome. A method for antenatal screening for chromosomal abnormalities is carried out by measuring body fluid taken from a pregnant woman for the level of at least one marker or precursor or metabolite of the marker together with the gestational age of the woman are compared with reference values taken from women carrying fetuses with chromosomal abnormalities and/or women carrying normal fetuses, using dimeric inhibin as a marker. A second marker is the free beta subunit of human chorion gonadotropin. An apparatus for carrying out the method described comprises a computer with a means for comparing the values described.

Abstract: A method for antenatal screening for chromosomal abnormalities in which maternal blood from a pregnant woman is measured for levels of free beta hCG and at least a second serum marker and/or precursors and metabolites of these markers and the measured levels of these markers together with the gestational age of the pregnant woman are compared to reference values at various gestational ages of the levels for free beta hCG and the second serum marker in (a) pregnant women carrying foetuses having the abnormalitie(s) subject to the screen and (b) pregnant women carrying normal foetuses, the comparison being indicative of the risk of the pregnant woman carrying a foetus with an abnormality subject to the screen characterised in that the second serum marker is pregnancy associated plasma protein A (PAPPA) and the screen is carried out by the end of the thirteenth (13th) completed week of pregnancy.

Abstract: There is disclosed a method for antenatal screening for an abnormality in a fetus using a bodily fluid, the fluid containing a marker which at one stage of gestation (stage A) the mean or median level) of the marker differs by less than 20% between pregnancies which are affected and unaffected by the abnormality and at another stage of gestation (stage B) differs by more than 50% between such affected and unaffected pregnancies, there being a period of at least 3 weeks between Stage A and Stage B and an apparatus for carrying out the method.

Abstract: The present invention provides a more accurate risk assessment of antenatal screening results because the maternal age of the patient is considered in evaluating the results from various common screening markers, and especially the results from UE determinations.

Abstract: A method for antenatal screening for chromosomal and other abnormalities in an unborn child is determined by measuring the gestational age discrepancy of the pregnant mother. This data is determined (a) by reference to the last menstrual period, and (b) a biometric measurement of the fetus. The difference between the ages as determined using (a) and (b) is calculated. This calculated difference is then examined using reference data to determine fetal abnormalities. These data can also be used with assay of maternal fluids for various pregnancy markers.

Abstract: An apparatus capable of receiving measurements relating to a fetus carried by a pregnant woman and computer means for comparing these measurements to reference data to determine fetal abnormalities. The measurements relate to the difference between the gestational age of the woman, as determined by reference to the menstrual period, and biometric measurement of the fetus. The apparatus can be used for antenatal screening for chromosomal abnormalities.